Samrat Pharmachem share news and announcements
BSE: 530125Pharmaceuticals & BiotechnologySmall Cap
Last close ₹277.50down ₹10.60 (3.68%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹288.10.
52-week range of traded prices to 23 Oct 2026
₹190.00Low, 30 Mar 2026₹309.85High, 30 Oct 2025
- Next results date: the board meets on 14 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹86 Cr3,210th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −2.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.16
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,601
Samrat Pharmachem share news and announcements
395 announcements, routine notices left out, newest first. Page 2 of 8.
Dec 2024
Nov 2024
Sep 2024
27 Sep · Board meeting
Meeting on 14 Nov 2024: quarterly results26 Sep · Meeting
Aug 2024
7 Aug · Management
Jul 2024
1 Jul · Board meeting
Meeting on 13 Aug 2024: quarterly results
Jun 2024
May 2024
Apr 2024
18 Apr · Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Year Ended March 31, 2024
10 Apr · Compliance Certificate Under Regulation 7(3) For The Period: 01St April 2023 To 31St March, 2024
Mar 2024
28 Mar · Board meeting
Meeting on 30 May 2024: audited results and final dividend
Feb 2024
29 Feb · Rating
Dec 2023
29 Dec · Board meeting
Meeting on 14 Feb 2024: quarterly results
Nov 2023
Sep 2023
26 Sep · Board meeting
Meeting on 8 Nov 2023: quarterly results26 Sep · Meeting
26 Sep · Meeting
Aug 2023
Jun 2023
30 Jun · Board meeting
Meeting on 14 Aug 2023: quarterly results
May 2023
30 May · Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023